Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Alzheimer's drugs
Biotech
Alzheon Alzheimer's drug knocked down in pivotal APOLLOE4 bout
Sixteen years after tramiprosate flunked a phase 3 trial, Alzheon’s prodrug form of the molecule has joined the lengthy list of Alzheimer’s failures.
Nick Paul Taylor
Apr 10, 2025 8:48am
AbbVie inks $1.4B Aliada buyout to land ex-J&J Alzheimer's drug
Oct 28, 2024 10:00am
Vivoryon Alzheimer’s drug fails phase 2 trial, crashing stock
Mar 4, 2024 8:13am
Silo’s Alzheimer's ketamine med reduces dementia signs in mice
Jan 25, 2024 12:09pm
'The Top Line': Unraveling Alzheimer's disease treatments
Oct 13, 2023 6:00am
Lilly reveals how Alzheimer's drug shapes up against Leqembi
Jul 17, 2023 10:15am
